These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the risk-benefit profile of the direct-acting P2Y(12) inhibitor ticagrelor in acute coronary syndromes. Husted S Postgrad Med; 2011 Nov; 123(6):79-90. PubMed ID: 22104457 [TBL] [Abstract][Full Text] [Related]
9. Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist. Azmoon S; Angiolillo DJ Catheter Cardiovasc Interv; 2013 Feb; 81(2):232-42. PubMed ID: 22581463 [TBL] [Abstract][Full Text] [Related]
10. ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly. Oprea AD; Popescu WM J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):779-95. PubMed ID: 23648080 [No Abstract] [Full Text] [Related]
11. Ticagrelor approved for acute coronary syndrome. Traynor K Am J Health Syst Pharm; 2011 Sep; 68(17):1568. PubMed ID: 21856798 [No Abstract] [Full Text] [Related]
12. Ticagrelor (Brilinta)--better than clopidogrel (Plavix)? Med Lett Drugs Ther; 2011 Sep; 53(1372):69-70. PubMed ID: 21897348 [TBL] [Abstract][Full Text] [Related]